Urine TGF-β1 concentration in patients with type 2 diabetes - prognostic value;Stȩżenie TGF-β1 w moczu u pacjentów z cukrzya̧ typu 2 - znaczenie prognostyczne

Polskie Archiwum Medycyny Wewnetrznej

Volumn 108, Issue 2, 2002, Pages 745-752

  Pa̧czek, Leszek ^a   Kropiewnicka, Hanna E ^a   Senatorski, Grzegorz ^a   Bartłomiejczyk, Irena ^a  

^a Transplantol i Chorob Wewnetrznych   (Poland)

Author keywords

Diabetic nephropathy; End stage renal disease; TGF

Indexed keywords

BIOLOGICAL MARKER; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BLOOD; CASE CONTROL STUDY; DIABETIC NEPHROPATHY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION AND FORECASTING; PROGNOSIS; RISK FACTOR; TIME; URINE;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0036673910     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mogensen C.E., Christensen C.K. Vittinghuse E.: The stages in diabetic renal disease: with emphasis on stage of incipient diabetic nephropathy. Diabetes, 1983, 32, (suppl. 2), 64.
2. Sebakowa K., Heidland A., Pa̧czek L.: Nefropatia cukrzycowa - aktualny stan wiedzy. Nefrol. Dial. Pol., 1999, 3, 74.
3. Pa̧czek L., Lao M.: Mechanizmy wioda̧ce do szkliwienia kłȩbków nerkowych. Pol. Tyg. Lek., 1993, 68, 442.
4. Mauer S.M., Steffes M.W., Ellis E.N. i wsp.: Structural-functional relationships in diabetic nephropathy. J. Clin. Invest., 1984, 74, 1143.
5. Yamamoto T., Nakamura T., Noble N.A.: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc. Natl. Acad. Sci. USA, 1993, 90, 1814
6. Danielpour D.: Improved sandwich enzyme-linked immunosorbent assay for transforming growth factor-β1. J. Immunol. Methods, 1993, 158, 17.
7. Sternber J.C.: A rate nephelometer for measuring specific protein by immunoprecipitin reactions. Clin. Chem., 1977, 23, 1456.
8. Rogulski J.: Diagnostyczne metody enzymologiczne oraz metody oznaczania glukozy, barwników żółciowych i niektórych niebiałkowych składników azotowych krwi. [w:] Biochemia kliniczna i analityka, (red.) S. Angielskiego. PZWL, 1990, 473.
9. Rossing P., Rossing K., Jacobsen P. i wsp.: Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes, 1995, 44, 739.
10. Sunagawa H., Iseki K., Nishime K. i wsp.: Epidemiologic analysis of diabetic patients on chronic dialysis. Nephron, 1996, 74, 361
11. Ziyadeh F.N., Sharma K.: Extracellular matrix metabolism in diabetic nephropathy. Role of transforming growth factor-β in diabetic glomerulosclerosis and renal hypertrophy. Kidney Int., 1995, 48, (suppl. 51), S-34.
12. Sharma K., Ziyadeh F.N.: Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse. Am. J. Physiol., 1994, 267, F 109.
13. Nakamura T., Miller. D., Ruoslahti E., Border W.A.: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-X31. Kidney Int., 1992, 41, 121.
14. Humes H.D., Nakamura T., Cieslinski D.A. i wsp.: Role of proteoglycans and cytosceleton in the effects of TGF-β on renal proximal tubule cells. Kidney Int., 1993, 43, 57.
15. Phillips S.L., DeRubertis F.R., Craven P.A.: Regulation of the laminin C1 promoter in cultured mesangial cells. Diabetes, 1999, 48, 2083.
16. Isaka Y., Fujiwara Y., Ueda N. i wsp.: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J. Clin. Invest., 1993, 92, 2597.
17. Baricos W.H., Shah S.V.: Proteolytic enzymes as mediator of glomerular injury. Kidney Int., 1991, 40, 1613.
18. Pa̧czek L., Teschner M., Schaefer M. i wsp.: Intraglomerular proteinase activity in adriamycin-induced nephropathy. Nephron, 1992, 60, 81.
19. Teschner M., Schaefer A.M., Pa̧czek L., Heidland A.: Effect of renal disease on glomerular proteinases. Miner. Electrolyte Metab., 1992, 18, 9.
20. Schaefer L., Schaefer R.M., Ling H. i wsp.: Renal proteinases and kidney hypertrophy in experimental diabetes. Diabetologia, 1994, 37, 567.
21. Heidland A., Sebekova K., Pa̧czek L. i wsp.: Renal fibrosis: Role of impaired proteolysis and potential therapeutic strategies. Kidney Int., 1997, 52, (suppl. 62), S-32.
22. Fagerudd J.A., Groop P.H., Honkanen E. i wsp.: Urinary excretion of TGF-β1, PDGF-BB and fibronectin in insulin-dependent diabetes mellitus patients. Kidney Int., 1997, 52, (suppl. 63), S-195.
23. Ellis D., Forrest K.Y.Z., Erbey J., Orchard T.J.: Urinary measurement of transforming growth factor-β and type IV collagen as of renal injury: application in diabetic nephropathy. Clin. Chem., 1998, 44, 950.